![cinclus pharma header news](/media/rendtiaq/cinclus-hero-news-4000x1200-04.jpg?rxy=0.32796912968121417,0.6878866892175145&width=1920&height=600&v=1d829a29bfc3eb0)
Media
News and press releases
Welcome to our media section. Check out the latest news and press releases from Cinclus Pharma and don’t hesitate to contact us if you need more information.
Latest pressreleases
Latest News
![Cinclus News Image Julander 02](/media/zevp1tjx/cinclus-news-image-julander-03.jpg?width=620&height=400&v=1db4be88ec172e0)
Bengt Julander on Cinclus Pharma in DITV
Bengt Julander, Chairman of one of Cinclus Pharma's largest shareholders, Linc, participated in DITV, saying Cinclus Pharma has the world's best stomach ulcer treatment.
![Skärmavbild 2024 12 03 Kl. 18.18.34](/media/zwsffcxn/cinclus-redeye.jpg?width=620&height=400&v=1db45ba391e9220)
Cinclus Pharma at Redeye Technology & Life Science Day
Watch the recorded presentation by CEO Christer Ahlberg at Redeye Technology & Life Science Day.
![Cinclus News Image Borsdagen](/media/ku1hgevh/cinclus-news-image-borsdagen.jpg?width=620&height=400&v=1db4253237bdb40)
Cinclus Pharma at Avanza’s Börsdag
Cinclus Pharma was presented by CEO Christer Ahlberg at Avanza’s Börsdag, Investor Day 2024.
![Cinclus Li Nbdirekt](/media/r0pfpbbj/cinclus-presentationer-nyhetsbyran-01.jpg?width=620&height=400&v=1db42393c7bb170)
Nyhetsbyrån Direkt about Cinclus Pharma
ABOUT 80-90% OF THE POTENTIAL FOR LINAPRAZAN GLURATE IN THE US
Cinclus Pharma in media
![Placera Logo](/media/jhynfyyw/placera_logo.jpg?width=52&height=52&v=1dac094f6f9a6a0)
Placera.se lists Swedish stocks offering the biggest upside
2025-01-02Cinclus Pharma is on the list of analysts' favorite stocks when Placera.se lists Swedish stocks offering the biggest upside.
![Ditv Logo](/media/hdljstxg/ditv_logo.jpg?width=52&height=52&v=1dac094f1338830)
Bengt Julander on Cinclus Pharma in DITV
2024-12-11Bengt Julander, Chairman of one of Cinclus Pharma's largest shareholders, Linc, participated in DITV, saying Cinclus Pharma has the world's best stomach ulcer treatment.
![Placera Logo](/media/jhynfyyw/placera_logo.jpg?width=52&height=52&v=1dac094f6f9a6a0)
Nyhetsbyrån Direkt about Cinclus Pharma: ABOUT 80-90% OF THE POTENTIAL FOR LINAPRAZAN GLURATE IN THE US
2024-11-28Nyhetsbyrån Direkt about Cinclus Pharma: ABOUT 80-90% OF THE POTENTIAL FOR LINAPRAZAN GLURATE IN THE US
![Redeye Ab Logo](/media/ormnj3ar/redeye_ab_logo.jpeg?width=52&height=52&v=1db0f682b399110)
Cinclus Pharma's CEO Christer Ahlberg interviewed by Redeye
2024-09-23Cinclus Pharma's CEO Christer Ahlberg was interviewed by Okee Williams at Redeye AB on September 23, about the company and the development of the drug candidate linaprazan glurate.
![Börspodden Logo](/media/epve2yb3/bo-rspodden_logo.jpeg?width=52&height=52&v=1db05c1d5d896d0)
Interview with Christer Ahlberg, CEO of Cinclus Pharma, in Börspodden
2024-06-26Christer Ahlberg, participated in Börspodden to talk about the listing and the upcoming plans for the company. Listen to the interview at 00:43:25 (in Swedish).